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Abstract
Background: Plasmodium falciparum parasitization of erythrocytes causes a substantial increase in the levels of intracellular
fatty acids, notably oleic acid. How parasites acquire this monounsaturated fatty acid has remained enigmatic. Here, we
report on the biochemical and enzymatic characterization of stearoyl-CoA desaturase (SCD) in P. falciparum.
Methodology/Principal Findings: Metabolic labeling experiments allowed us to demonstrate the production of oleic acid
from stearic acid both in lysates of parasites incubated with [
14C]-stearoyl-CoA and in parasite-infected erythrocytes labeled
with [
14C]-stearic acid. Optimal SCD activity was detected in schizonts, the stage of maximal membrane synthesis. This
activity correlated with a late trophozoite stage-specific induction of PFE0555w transcripts. PFE0555w harbors a typical SCD
signature. Similar to mammalian SCDs, this protein was found to be associated with the endoplasmic reticulum, as
determined with PFE0555w-GFP tagged transgenic P. falciparum. Importantly, these parasites exhibited increased rates of
stearic to oleic acid conversion, providing additional evidence that PFE0555w encodes the plasmodial SCD (PfSCD). These
findings prompted us to assess the activity of sterculic acid analogues, known to be specific D9-desaturase inhibitors.
Methyl sterculate inhibited the synthesis of oleic acid both with parasite lysates and infected erythrocytes, most likely by
targeting PfSCD. This compound exhibited significant, rapid and irreversible antimalarial activity against asexual blood
stages. This parasiticidal effect was antagonized by oleic acid.
Conclusion/Significance: Our study provides evidence that parasite-mediated fatty acid modification is important for
blood-stage survival and provides a new strategy to develop a novel antimalarial therapeutic based on the inhibition of
PfSCD.
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Introduction
Plasmodium falciparum causes the most severe form of malaria
and is the most widespread parasitic disease, affecting nearly
40% of the world population [1]. Up to 500 million clinical
cases are reported each year a n dm o r et h a n1m i l l i o nd i e
annually, causing a devastating impact on the health and
economic productivity of afflicted communities. Despite the
availability of several licensed drugs, the emergence of multi-
drug resistant strains has dramatically decreased the effective-
ness of many antimalarial treatments. The development of new
compounds involving novel targets and mechanisms of action is
an urgent priority.
The establishment of the intraerythrocytic P. falciparum infection
is associated with a large increase in the phospholipid, neutral lipid
and lipid-associated fatty acid (FA) content in infected red blood
cells (IRBCs). Intraerythrocytic proliferation largely relies on FAs
derived from human serum, as shown by experiments in which
parasite growth was not sustained with culture medium lacking
these FAs [2,3,4,5]. These studies imply that serum-derived
saturated and unsaturated FAs are required for P. falciparum
growth and that scavenging FAs from serum is critical for survival
during the erythrocytic cycle [5,6]. FA incorporation is likely to
occur by passive diffusion through the membranes of the
parasitized red blood cells (RBC) and the internal parasitophorous
vacuole [7]. In contrast to most other organisms, where both de
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membrane homeostasis, P. falciparum reportedly has only minimal
capacity to elongate FA during intraerythrocytic infection [7].
Sequencing of various plasmodial genomes has revealed
members of the type II fatty acid (FAS-II) biosynthetic machinery,
suggesting that P. falciparum can synthesize FAs de novo from acetate
[8]. An earlier biochemical study reported evidence that this
pathway is responsible for the synthesis of short-chain FAs and
that its inhibition, by the FAS-II inhibitor triclosan, was lethal for
the parasite [9]. This led to the idea that P. falciparum satisfies its
FA requirement by scavenging free FAs present in the serum or
released by the action of lipases from the lipids, and also by
catalyzing de novo synthesis by FAS-II. Recent work, however,
suggests that the FAS-II pathway is active only in liver stages and is
non-essential for asexual blood stage parasites [10,11]. These
findings imply that asexual blood stages rely solely on import of
host FAs. Whether these FAs can be modified during intraeryth-
rocytic growth, including via mechanisms of desaturation, has until
now not been investigated.
Earlier reports provided evidence that the intraerythrocytic P.
falciparum parasite can salvage free FAs from the external milieu
and incorporate them into its lipids without any structural
modification [5,12]. However, the presence of a putative
stearoyl-CoA D9-desaturase (SCD), as well as several acyl-CoA
synthetases, suggests that P. falciparum is capable of also modifying
host FAs [5]. SCD is an enzyme responsible for the biosynthesis of
monounsaturated FAs from saturated FAs. This iron-dependent
enzyme catalyzes the insertion of a cis double bond at the D9
position of fatty acyl-CoAs with NADPH as a cofactor [13].
Several SCDs have been identified and characterized in mammals,
including humans, where they have been implicated in conditions
of diabetes or obesity [14]. Recently, there has been a surge of
interest in the use of SCDs as chemotherapeutic targets for the
treatment of various diseases, including metabolic disorders and
infectious diseases. This is exemplified by the fact that the
Mycobacterium tuberculosis SCD (termed DesA3) has been shown to
be a target of the antitubercular drug isoxyl [15].
In the present study, we have undertaken a biochemical and
enzymatic analysis of the putative P. falciparum desaturase,
predicted to be required for oleic acid (C18:1) biosynthesis. The
detection of D9-desaturase activity led us to investigate the effect of
a specific D9-desaturase inhibitor on parasite viability. We
conclude by discussing the potential of this class of inhibitors
and the data that support PfSCD as a potential target for
antimalarial intervention.
Methods
Parasite strains and cultures
The P. falciparum 3D7 strain was used for metabolic labeling and
drug susceptibility testing. Using the Petri dish candle-jar method,
parasites were cultured in vitro in complete medium, i.e. RPMI-
1640 medium supplemented with 25 mM Hepes (Gibco) and 10%
AB
+ human serum [16]. The human red blood cells and sera were
provided by the local Blood Center in Montpellier (France), in
accordance with French legislation. The concentration of human
serum in the medium was lowered to 4% for biochemical assays
and drug susceptibility testing. In transfected parasites, human
serum was replaced by 0.5% Albumax I (Gibco). Dd2
attB and
3D7
attB strains were grown in complete medium containing
2.5 nM WR99210 (Jacobus Pharmaceutical Co.) [17]. Synchro-
nization of parasite cultures for stage-specific analyses was
performed using 5% sorbitol [18].
Molecular cloning, DNA constructs and E. coli strains
All PCR experiments were performed using the Phusion DNA
Polymerase (Finnzymes). Restriction enzymes were purchased
from New England Biolabs. The Plasmodium-specific pLN-ENR-
GFP and pINT plasmids were described previously [17]. E. coli
Top10 cells were from Invitrogen, whereas XL10 Gold and
BL21(DE3) were from Stratagene.
Generation of PfSCD-GFP transgenic parasites
Overexpression of a Pfscd-gfp transgene in P. falciparum was
performed using the attB recombination system recently developed
by Nkrumah et al. [17]. This system enables site-specific, stable
integration of a gene of interest in Dd2
attB and 3D7
attB strains,
which contain a mycobacterial attB recombination site inserted
into the non-essential cg6 locus. Recombination requires transfec-
tion with two plasmids: pINT that expresses the mycobacterioph-
age Bxb1 integrase and a neomycin selectable marker conferring
resistance to G418, and pLN-ENR-GFP that permits expression of
a gene of interest fused to gfp and that contains the mycobacterial
attP recombination sequence as well as a blasticidin resistance
cassette. Transgene expression is driven by the calmodulin
promoter. We also generated a transgenic 3D7 line that replicated
pLN-SCD-GFP as episomal copies.
The full-length 3 kb Pfscd gene was amplified from purified P.
falciparum 3D7 genomic DNA using primers 59-ACC TAG GTG
ATA AAT GAT AGA AAT GAT CTT AAG TTA TG-39 (AvrII
site underlined) and 59-A CG TAC GTA AGA ATT CCT TTA
GTA CGT CC-39 (BsiWI site underlined). DNA amplification was
performed using the following conditions: denaturation (94uC,
45 sec), annealing (42uC, 45 sec), polymerization (62uC, 3 min).
This DNA fragment was cloned into pLN-ENR-GFP, replacing
the DNA fragment encoding PfFabI (also known as PfENR), to
yield pLN-SCD-GFP.
Synchronized ring stage Dd2
attB and 3D7
attB parasites (at 5–8%
parasitemia) were electroporated with 75 mg of pLN-SCD-GFP
and 50 mg of pINT [19]. Transfectants were selected in complete
medium containing 2.5 mg/ml blasticidin (BSD, Sigma) and
125 mg/ml G418 (Invitrogen) until the emergence of transgenic
parasites. Genomic DNAs from transgenic parasites and parental
strains were recovered using the QIAamp DNA Blood Mini Kit,
and site-specific integration of the cassette was confirmed with
PCR. The following primer pairs were used: p1 (59-ATG AAC
AAA TAC ATA AGA GCG CC-39) plus p2 (59-ATG CAT GCC
AAG CCT TTG TCT AAG-39), and p3 (59-ACC TAG GTG
ATA AAT GAA TAT AAA TTT ATT CAA AAG AAT G-39)
plus p4 (59-CCT TCA CCC TCT CCA CTG ACA G-39). For
episomal expression, parasites were transfected and maintained in
culture under BSD selection.
Live Imaging
Live Dd2
attB::Pfscd-gfp infected erythrocytes were observed in
PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,2m M
KH2PO4), or HBSS (Gibco) on a Zeiss Axiovert 200 M
epifluorescence microscope. The endoplasmic reticulum (ER)
and the mitochondria were stained respectively with 0,5 mME R
Tracker Red or 20 nM MitoTracker Red (both from Molecular
Probes) in HBSS supplemented with Ca
2+ and Mg
2+ (product
reference 14025, Gibco) for 30 min at 37uCi naC O 2 incubator.
The nuclei were stained with cell permeant Hoechst H33342
(Sigma) for 5 min at room temperature (RT).
Immunofluorescence assays
PfSCD-GFP infected RBC were fixed in 4% paraformaldehyde
containing 0.0075% glutaraldehyde (both from EMS sciences) in
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containing0.1 Mglycinefor15 minat RT,andthen permeabilized
with 0.1% Triton X-100 in PBS for 10 min at RT. IRBC were
resuspended in1%fetalcalfserum(FCS)inPBSandincubatedwith
the primary antibodies for 1 h at RT. After 3 washes in 1% FCS,
cells were incubated with the secondary antibodies (1 h, RT),
washed and layered on poly-L-Lysine coated immunofluorescence
slides and mounted with Vectashield containing DAPI (Vector
laboratories). All antibodies were diluted in 1% FCS: rat anti-PfBiP
(1/5000 dilution) and rat anti-PfERD2 (1/1000 dilution) were from
the MR4, purified rabbit anti-PfDisulfide Isomerase (1/500
dilution) was a gift from Pr P. Grellier, whereas rabbit anti-ACP
(1/1000) was kindly provided by Pr. G. McFadden. Secondary
antibodies, anti-rat or anti-rabbit Alexa fluor 594 nm (Molecular
probes) were used at a 1/2000 dilution. Samples wereobserved on a
Zeiss Axioimager epifluorescence microscope equipped with an
Apotome for optical sectioning, using a 100X or a 63X apochromat
1.4 objective and differential interference contrast (DIC) for
transmitted light.Images were processed with Axiovision, or ImageJ
softwares. Image acquisition and image analysis were performed on
workstations of the Montpellier RIO Imaging facility of MRI-DBS.
Quantitative RT-PCR on time course samples P.
falciparum mRNA
Total RNA was extracted from tightly synchronized P. falciparum
106/1 parasites during a 48 hrs growth period in a bioreactor
(Applikon). RNA was purified as described in [21]. Contaminating
DNA was removed following RQ1 DNase treatment (Promega).
Double stranded cDNAs were synthesized using Superscript III
Reverse Transcriptase (Invitrogen). Quantitative PCR was
performed using SYBRGreen (Invitrogen) as a fluorescent probe
in an Opticon2 (BioRad). Pfscd was amplified using the forward
primer 59-GGG ATT TAA AAT GTG CAA AGA AT-39 and the
reverse primer 59-GCA TTG TGT AAT GAT TAT TTA AAT
A-39. The Pfactin gene, used as a reference, was amplified using the
forward primer 59-AGC AGC AGG AAT CCA CAC A-39 and
the reverse primer 59-TGA TGG TGC AAG GGT TGT AA-39.
MJ Research Opticon Software (BioRad) was used to analyze the
data. Pfscd and Pfactin copy numbers were determined by the
absolute quantification method using a standard set of reactions of
P. falciparum 106/1 genomic DNA of known copy number.
Conversion of stearic acid into oleic acid in P. falciparum
Desaturase activity was determined at successive developmental
stages of a synchronized in vitro P. falciparum culture. The assay was
developed in 24-well plates containing IRBCs at 5% hematocrit
and 5% parasitemia in a final volume of 1 ml. IRBCs were labeled
for 4 hrs at 37uC with 1 mCi [
14C]-stearic acid (C18:0; 56 mCi/
mmol, Sigma; corresponding to a final concentration of 18 mM).
Parasites were then washed once with cold PBS, transferred into
glass tubes, and subjected to alkaline hydrolysis using 2 ml of 15%
aqueous tetrabutylammonium hydroxide (TBAH, Sigma) over-
night at 100uC. This step was followed by the addition of 2 ml of
water, 4 ml of dichloromethane and 300 ml of methyl iodide, and
tubes were agitated for 1 hr at RT. The upper aqueous phase was
discarded while the lower organic phase was washed twice with
water and dried by evaporation. Fatty acid methyl esters (FAMEs)
were dissolved in diethyl ether and evaporated. The final residue
was then dissolved in 200 mlo fC H 2Cl2. Equal counts (or equal
volumes) of the resulting solution were subjected to 10% silver
nitrate-impregnated thin-layer chromatography (TLC) using silica
gel 1D plates (5735 silica gel 60F254; Merck). Labeled FAs were
resolved in petroleum ether/diethyl ether (17/3, v/v) and
autoradiograms were obtained by exposing the plate to a Kodak
Biomax MR film to reveal [
14C]-labeled FAMEs. Silver nitrate
was used to separate saturated from unsaturated FAs, as the latter
were retarded during migration [22]. Spots corresponding to the
oleic acid methyl esters (OAMEs) were identified using a
radiolabeled standard, then scraped, resuspended in scintillation
liquid (UltimaGold, Perkin-Elmer) and quantified using a Beck-
man Coulter LS 6500 Scintillation Counter.
Substrate specificity was investigated as described above, except
that parasites were labeled for 4 hrs at 37uC with either 1 mCi
[
14C]-stearic acid or 1 mCi [
14C]-palmitic acid (56 mCi/mmol,
Sigma) (each final concentration was 18 mM).
Inhibition of oleic acid synthesis in schizonts was investigated as
described above, except that parasites were pre-incubated with
methyl ester of cyclopropene fatty acid for 1 hr prior to the
addition of [
14C]-stearic acid (18 mM final concentration) and then
incubated a further 4 hrs at 37uC.
Cyclopropene fatty acids
Methyl esters of cyclopropene fatty acids were prepared from
1,1,2-tribromo-2-octylcyclopropane by a slight modification of the
methods previously described [23,24]. Experimental details are
presented in Methods S1.
In vitro stearoyl-CoA desaturase assay
Schizont-IRBCS (40 hrs post-synchronization) were harvested
by centrifugation, treated with 0.05% saponin, washed once with
RPMI 1640+ Hepes, and resuspended in 0.1 M potassium
phosphate buffer pH 7.2 supplemented with an antiprotease
cocktail (Roche Diagnostics). Schizonts were then sonicated for
30 sec and their protein content quantified using the BCA Protein
Assay Reagent kit (Interchim). Cell-free desaturase activity was
assayed as described previously [25], with limited modifications.
Lysates were incubated with 2 mM NADPH and [
14C]-stearoyl-
CoA (56 mCi/mmol American Radiolabeled Chemicals) in a final
volume of 100 ml for 5 min at 37uC. The reaction was stopped by
adding 2 ml of TBAH. FAMEs were extracted, resolved by silver
nitrate TLC, exposed to a film and oleic acid was quantified as
described above.
In inhibition assays, schizont lysates were pre-incubated with
increasing concentrations of the methyl ester of the cyclopropene
fatty acid for 10 min at 37uC prior to the addition of 2 mM
NADPH and 20 mM[
14C]-stearoyl-CoA. Samples were then
processed as described above.
NADPH and NADH dependency was investigated in an in vitro
assay that used parasite membranes instead of crude lysates.
Membranes (equivalent to 350 mg of proteins) were recovered by
ultracentrifugation of the total extract at 100, 0006g for 20 min at
4uC, washed twice with potassium phosphate buffer and assayed
for desaturase activity. After a 10 min pre-incubation at 37uC,
20 mM[
14C]-stearoyl-CoA was added to the mixture in the
absence or presence of either 2 mM NADPH or NADH. Samples
were then processed as described above.
Lipid analysis
Lipid composition was investigated with or without treatment
with methyl sterculate (MeSter) as follows. Total lipids were
extracted using 3 ml of a chloroform:methanol (2:1, v/v) mixture
[26]. After 3 hrs of incubation, 550 ml of 0.1 M KCl was added
and tubes were mixed gently for another 1 hr. The upper aqueous
phase was discarded and the organic phase was washed twice with
a chloroform:methanol:water (3:48:47, v/v) mixture, then dried
and resuspended in chloroform:methanol (2:1, v/v). Equal
amounts of radioactivity for each sample were loaded onto TLC
plates. Phospholipids were resolved using chloroform:methanol:a-
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neutral lipids were separated with heptane:diisopropyl oxide:acetic
acid (60:40:3, v/v/v) [3].
Drug susceptibility testing to methyl-sterculate (MeSter)
and its analogs
The effect of MeSter and its structural analogs on P. falciparum
growth was determined using a modified Desjardins test [27].
Assay wells contained 0.25% DMSO or less. 0.5 mCi of [
3H]-
hypoxanthine (19.4 Ci/mmol, GE Healthcare) was added after
48 hrs of contact, while parasite viability was determined by
measuring [
3H]-hypoxanthine incorporation after 18 hrs. Lysed
parasites were harvested on filters using a Filtermate Harvester
(Perkin Elmer) filled with 30 ml of scintillation liquid (Microscint,
Perkin-Elmer), sealed, and counted in a TopCount NT Counter
(Perkin Elmer).
Drug inhibition of in vitro cultured P. falciparum growth
A two-step method was applied to synchronize the parasites.
First, we used a magnetic cell sorter (VarioMacs, Miltenyi Biotec)
that mainly retains schizonts [28], and second we used 5% sorbitol
treatment 6 to 8 hrs later to selectively lyse mature stages [18].
Stage-dependent susceptibility was studied by adding MeSter at
various concentrations when the parasites were in the ring (4 hrs
after sorbitol treatment), trophozoite (20 hrs after sorbitol
treatment), or schizont (33 hrs after sorbitol treatment) stages.
Assays were initiated at 1% hematocrit and 0.6% parasitemia and
MeSter was added for 6 hrs. Cells were then washed twice and
resuspended in fresh complete medium. The course of in vitro P.
falciparum growth inhibition was evaluated for these three stages.
MeSter was added at 870 mM to synchronized cultures. After
various lengths of incubation, cells were washed twice and
resuspended in fresh complete medium. For both experiments,
[
3H]-hypoxanthine (0.5 mCi/well) was added at 52 hrs to monitor
parasite viability. Reactions were stopped at 70 hrs and viability
was evaluated for each stage and expressed as a percentage of the
control (without drug).
Effect of MeSter on P. falciparum morphology
P. falciparum parasites were synchronized with 5% sorbitol and
MeSter was added 6 hrs later. Parasite morphology was evaluated
by examination of blood smears every 6 hrs until reinvasion, i.e.
52 hrs post synchronization. Giemsa-stained blood smears were
examined using a Nikon Eclipse 80i microscope and a Nikon DS-
2Mv digital camera.
Data analysis
Determination of enzyme kinetics, and IC50 and inhibition
curves with MeSter and its analogues were generated using the
Prism 5.0 software (GraphPad Inc.).
Results
Identification of a putative plasmodial stearoyl-CoA
desaturase
In silico analysis of the P. falciparum 3D7 genome sequence [29]
revealed the presence of a gene (PFE0555w) encoding a putative
stearoyl-CoA D9-desaturase (PfSCD). This 2-exon gene encodes a
protein of 949 amino acids (114 kDa, predicted pI of 9.2).
Alignments of PfSCD with eukaryotic SCDs from human, M.
musculus and D. melanogaster indicate that the malarial sequence is
well conserved (Fig. 1). The identity rates between the central
domain (residues 366 to 622) of PfSCD and these three eukaryotic
orthologs are 41%, 38% and 42%, respectively. This central
domain contains the catalytic domain of the SCD [13], comprising
the three Histidine-Boxes designated region Ia, Ib and II (Fig. 1).
All eight conserved His residues are essential for stearoyl-CoA
desaturase activity, as mutations of any of these residues abrogate
enzymatic activity [13]. D9-desaturase activity requires two co-
acting enzymes, the cytochrome b5 and NADPH cytochrome b5-
reductase [30] that were also found to be present in the P.
falciparum genome (accession numbers Q8I599 and Q8ID33,
respectively). The cytochrome b5 reductase provides cytochrome
b5 with electrons and protons extracted from NADPH. These
attach to HisBox of SCD through two iron atoms and attaches two
protons and two electrons to the fatty acyl-CoAs [31].
The plasmodial SCD appears as an unusually large SCD
protein with the presence of additional N-terminal and C-terminal
sequences (Fig. 1). These extra domains are also shared by other
Plasmodium species. The overall amino acid sequence of PfSCD is
well conserved in all plasmodial species with sequence identities of
74%, 71%, 71% and 70% compared to P. vivax, P. yoelii, P. berghei
and P. chabaudi respectively (Figure S1). The ubiquitous presence of
this protein in all sequenced Plasmodium species strongly suggests
that it is probably fulfilling important physiological functions. An
unexpected feature of PfSCD is the presence of eighteen predicted
transmembrane domains (Fig. 1), in contrast with most eukaryotic
SCDs that contain two to four transmembrane regions [32,33,34].
This high number of transmembrane domains may have hindered
us from producing the full-length or the central domain of PfSCD
in E. coli, despite repeated attempts.
D9-desaturase expression and activity in P. falciparum
Our first set of experiments confirmed that P. falciparum could
synthesize oleic acid from exogenous stearic acid in non-
synchronous IRBCs (data not shown). This finding agrees with
Mi-Ichi et al. [35]. We next examined the Pfscd transcriptional
profile through a complete erythrocytic cycle. Total mRNA was
extracted from cultured, tightly synchronized P. falciparum 106/1
parasites every 6 hrs. Quantitative RT-PCR was performed on
stage-specific mRNA and compared to a control Pfactin reference
gene. As shown in Fig. 2A, Pfscd transcripts were predominantly
expressed during the late trophozoite stage (between 30 and
42 hrs). There was a 53-fold increase of Pfscd transcript expression
level between 18 and 36 hrs. In comparison, the Pfactin transcript
expression level increased 19-fold between 18 and 36 hrs.
Comparable results with respect to Pfscd mRNA induction were
also obtained in cultured P. falciparum 3D7 parasites (data not
shown). We subsequently investigated whether this could be
correlated to a stage-specific D9-desaturase activity throughout the
whole asexual parasitic cycle. For this experiment, different blood
stages (rings, trophozoites and schizonts) were pulsed with [
14C]-
stearic acid. FAMEs were then extracted and analyzed by TLC on
silver nitrate-impregnated plates to discern saturated from
unsaturated FAs. Autoradiography presented clear evidence that
no oleic acid was produced in IRBCs cultured at 4uC, whereas it
was produced in schizonts at 37uC. No significant oleic acid levels
were detected in rings and trophozoites (Fig. 2B). Schizonts
produced 4.0 nmoles of oleic acid/10
10 cells/hr, whereas rings
produced 0.2 nmoles of oleic acid/10
10 cells/hr. Overall, these
results suggest that oleic acid is the product of an active
developmental stage-specific process occurring at the late stage
of the intraerythrocytic cycle.
Mammalian D9-desaturases have been the focus of considerable
research in recent years [36,37,38]. Typically, mammals contain
several SCDs that usually prefer stearoyl-CoA and palmitoyl-CoA
as substrates. However, enzyme-substrate affinities and enzyme
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determine the preferred substrate of P. falciparum D9-desaturase,
schizonts were labeled with 18 mM of either [
14C]-stearic acid
(C18:0;1 mCi/ml) or [
14C]-palmitic acid (C16:0;1 mCi/ml).
Autoradiograms of the FAs produced evidence of an unsaturated
product, corresponding to oleic acid methyl ester, only when
[
14C]-stearic acid was supplied as a substrate (Fig. 2C). No
palmitoleic acid (C16:1) was detected when parasites were provided
with the substrate [
14C]-palmitic acid. This indicates that, in
contrast to most characterized mammalian D9-desaturases, the
plasmodial D9-desaturase has a strong affinity for stearic acid with
no observable activity on palmitic acid.
Oleic acid synthesis in transgenic parasites
overexpressing PFE0555w
A transgenic P. falciparum cell line constitutively overexpressing a
PfSCD-GFP fusion was generated using the site-specific integra-
tion system developed by Nkrumah et al. [17]. Both pINT
(containing the integrase) and pLN-SCD-GFP (containing the
Pfscd-gfp sequence along with the attP site) were co-transfected into
the recipient 3D7
attB strain carrying the cg6-attB locus and selected
using BSD and G418. This resulted in a transgenic line termed
3D7
attB::PfSCD-GFP, in which the Pfscd-gfp sequence was
integrated into the chromosomal attB site (Fig. 3A). Proper
integration of the Pfscd-gfp transgene was confirmed by PCR using
specific primers (Fig. 3A).
We first performed quantitative RT-PCR to compare the
expression level of Pfscd transcripts in the 3D7
attB::PfSCD-GFP
and 3D7
attB strains. Parasites were synchronized, and total mRNA
was extracted from early trophozoites (around 27 hrs). Quantita-
tive RT-PCR indicated a 17% increase of Pfscd transcripts in the
transgenic parasites containing the Pfscd-gfp construct, a value
considered to be significant as revealed by the Student t test
(P,0.01, data not shown). Second, both the parental and
transgenic P. falciparum parasites were labeled with 18 mM[
14C]-
stearic acid at a late ring stage. Labeled FAs were extracted and
analyzed by TLC as mentioned above. Rings were chosen due to
their low oleic acid background level. As shown in Fig. 3B (upper
panel), the overexpression of PFE0555w was associated with a
significant increase in oleic acid production compared to the
parental strain. Quantification of the radioactive spots corre-
sponding to oleic acid methyl esters indicated that 3D7
attB::Pfscd-
gfp reproducibly exhibited a 2-fold increase in oleic acid synthesis
with respect to 3D7
attB (Fig. 3B, lower panel). Similar results were
Figure 1. Aligned sequences of stearoyl-CoA D9-desaturases. Multiple sequence alignment was performed using CLUSTALW (http://www.ebi.
ac.uk/Tools/clustalw2/index.html) and the BoxShade package (http://www.ch.embnet.org/software/BOX_form.html). P. falciparum SCD (GenBank
accession number Q8I0W9) was compared with human SCD1 (accession number: O60427), Mus musculus SCD1 (accession number Q547C4) and
Drosophila melanogaster SCD1 sequence (accession number Q7K4Y0). PfSCD transmembrane domains were predicted using the TMHMM package
(http://www.cbs.dtu.dk/services/TMHMM-2.0/) and are shown in grey. Stars indicate the eight conserved His residues (2 in region Ia, 3 in region Ib,
and 3 in region II). Identical amino acid residues are in black and homologous residues are shaded in grey. Gaps were introduced to facilitate the
sequence alignment. The ER retention KDEL motif is indicated by a double black line.
doi:10.1371/journal.pone.0006889.g001
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parasites (data not shown). Together, these results strongly suggest
that PFE0555w encodes the plasmodial stearoyl-CoA desa-
turase.
Kinetics of P. falciparum stearoyl-CoA D9-desaturase
To determine the desaturase kinetic parameters, we developed
a cell-free assay using lysates of P. falciparum 3D7 schizonts
incubated with NADPH and [
14C]-stearoyl-CoA. After comple-
tion of the reaction, the mixture was hydrolyzed. From this, total
FAs were extracted, and methyl-esterified prior to analysis by
silver nitrate TLC. In a first set of experiments, we analyzed oleic
acid production as a function of protein concentration (Fig. 4A).
The curve appeared linear in a 0–500 mg schizont protein
concentration range. Because 500 mg caps the linear phase of the
curve, this amount was used in all subsequent experiments. The
velocity of the reaction was determined by analyzing stearoyl-
C o Ac o n v e r s i o ni n t oo l e o y l - C o Ao v e rt i m e( F i g .4 B ) .O l e i ca c i d
was produced after 10 min, demonstrating very rapid reaction
kinetics. Subsequent experiments concluded that the kinetic
curve was linear during the first 5 min of the reaction (data not
shown).
The kinetic parameters of stearoyl-CoA D9-desaturase activity
were measured by incubating crude schizont extracts with
increasing concentrations of radiolabeled stearoyl-CoA (Fig. 4C,
left panel). The curve obtained from quantification of synthesized
oleic acid displayed a typical shape, indicative of Michaelis-
Menten kinetic characteristics. An apparent Km value of 56.6 mM
and a Vmax of 1.15 mmol/hr/mg were determined as a mean of 2
independent experiments, with a variability of less than 25%
between experiments (Fig. 4C, right panel). We note that these
kinetic parameters reflect the SCD activity in schizont extracts,
although one cannot exclude the possibility of separate enzymes
that may contribute to the catalytic activity described.
We next investigated the NADPH and NADH dependency of
this reaction. As shown in Fig. 4D, no oleic acid was produced in
the absence of NADPH in the assay. When NADPH was
substituted by NADH, only a very weak signal corresponding to
oleic acid could be observed, suggesting that PfSCD is mainly
dependent on NADPH. Because this assay was performed using
parasite membranes, the presence of a D9-desaturase activity
suggests that PfSCD is very likely to be associated to membranes.
This prompted us to further investigate the localization of PfSCD
in the parasite.
Figure 2. Stage-specific expression of Pfscd and stearoyl-CoA desaturase activity in P. falciparum. (A) Transcriptional profile of Pfscd
(PFE0555w) as determined using quantitative RT-PCR. Total mRNA from synchronized P. falciparum was extracted every 6 hrs for one complete cycle
(48 hrs). The mRNA was reverse-transcribed and the cDNA subjected to quantitative PCR using Pfactin as a reference gene. Results are expressed as
transcript copy numbers, presented as the mean6SEM of 2 independent experiments performed in triplicate. (B) In vivo stearoyl-CoA desaturase
activity. Various parasite stages were labeled with [
14C]-stearic acid for 4 hrs either at 4uCo r3 7 uC prior to extraction of the fatty acid methyl esters
(FAMEs). Equal volumes of each sample (30%) were loaded on the TLC plate and resolved using petroleum ether/diethyl ether (17/3, v/v). C18:0 and
C18:1 methyl esters were used as standards (indicated by arrowheads). Autoradiograms were exposed overnight to a Kodak Biomax MR film to reveal
[
14C]-labeled FAMEs. This autoradiogram is representative of results obtained in two independent experiments. (C) Substrate specificity of PfSCD.
Schizonts were labeled with either radiolabeled palmitic acid (C16:0) or stearic acid (C18:0) for 4 hrs at 37uC. Following extraction, equal volumes were
loaded on a TLC plate and FAMEs were resolved along with C18:0 and C18:1 methyl esters as standards using petroleum ether/diethyl ether (17/3, v/v).
These were revealed after overnight exposure to a Kodak Biomax MR film.
doi:10.1371/journal.pone.0006889.g002
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The subcellular localization of PfSCD during intraerythrocytic
infection was studied using PfSCD-GFP parasites. In most
parasites, the green fluorescence surrounded the nucleus of the
parasite stained in blue with Hoechst H33342 (Fig. 5A, GFP in
green). This distribution is typical of the nuclear envelope and is
considered as the main ER compartment in Plasmodium [41,42,43].
This was confirmed by the colocalization of the GFP green
labeling with ER tracker red, a Glibenclamide-bodipy compound
that shows a high affinity for the ER membrane (Fig. 5A). ER
tracker has been widely used as an ER marker for fluorescence
microscopy in various cell types. However, because ER tracker
may also lead to non ER-membrane labeling depending on the cell
type, we further investigated the sub-cellular localization of PfSCD
by performing a detailed immunofluorescence analysis. As shown
in Fig. 5B, PfSCD-GFP colocalized mostly with PfBiP and PfDSI
(disulfide isomerase), two soluble ER markers [41,43], therefore
confirming the ER localization of PfSCD-GFP. In contrast, the
GFP-tagged PfSCD protein did not colocalize with ERD2, a
known marker of the cis-Golgi [41,44]. The perinuclear labeling
was consistent all throughout the intraerythocytic stage. Prolife-
ration and branching were also observed during parasite
maturation, in agreement with the description of the evolution
of the ER during the parasite blood stage cycle [42,45]. The GFP
labeling was sometimes observed as a bright sub-domain of the
nuclear envelope (Fig. 5A), or was closely apposed to the plasma
membrane of the parasite, suggesting a dual localization to
another organelle such as the mitochondria or the apicoplast, in
addition to the ER. This issue was addressed by colocalization
studies with MitoTracker red and apicoplast-specific anti-ACP
antibodies. As shown in Fig. 5B, the mitochondria labeling
appeared clearly distinct from the GFP signal at any erythrocytic
stage. Moreover, the apicoplast did not colocalize with PfSCD-
GFP, although it was often observed to be tightly apposed to
particular domains of the GFP-labeled membrane. Taken
together, these results confirm the ER membrane localization of
PfSCD, which is consistent with the ER localization of SCDs
previously described in mammals, such as mice and rats [34]. This
is also consistent with the presence of a KEFL motif in the extreme
C terminus of the protein (Fig. 1), which is closely related to the
typical ER retention signal KDEL [46,47].
Inhibition of the D9-desaturase by methyl sterculate
To evaluate the essentiality of oleic acid during intraerythrocytic
growth, we tested selective D9-desaturase inhibitors. Sterculic acid
is a cyclopropene-containing FA, naturally found in plants such as
Figure 3. Stearic to oleic acid conversion in parasites overexpressing a Pfscd-gfp transgene. (A) Schematic diagram of the cotransfected
plasmids, the recipient cg6-attB locus and the recombinant locus produced upon integration of the Pfscd-gfp cassette (upper panel). The lower panel
represents integration of Pfscd-gfp into the cg6-attB locus of 3D7
attB::Pfscd. Lane 1: 1 kb ladder. Lanes 2&4: integration of the blasticidin cassette into
the locus was assayed by PCR using primers p1 and p2. Lanes 3&5: the presence of the complete Pfscd-gfp fusion was detected using primers p3 and
p4. Lane 2&3: control 3D7
attB strain. Lane 4&5: 3D7
attB::Pfscd-gfp line. (B) 3D7
attB and 3D7
attB::Pfscd-gfp rings were labeled with 1 mCi of [
14C]-stearic
acid for 6 hrs at 37uC. Following extraction, equal counts (40,000 cpm) were loaded on a 10% silver nitrate-impregnated TLC plate. FAMEs were
resolved using petroleum ether/diethyl ether (17/3, v/v) and revealed after overnight exposure to a Kodak Biomax MR film. The upper panel shows
the fatty acid profile of two independent samples of each strain. Oleic acid methyl esters were scraped from the TLC plate and counted. Results are
expressed as a fold increase of oleic acid production (normalized to a value of one in the 3D7
attB strain). The data in the lower panel represent the
means of 4 experiments with standard deviations.
doi:10.1371/journal.pone.0006889.g003
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desaturation of stearic to oleic acid [48,49]. Recent work has
revealed potent antimycobacterial activity of sterculic acid
targeting the stearoyl-CoA desaturase DesA3 in Mycobacterium
tuberculosis [15]. Herein, we examined whether its methyl ester
(methyl sterculate, MeSter) might inhibit oleic acid biosynthesis by
targeting the P. falciparum stearoyl-CoA desaturase. In the first set
of experiments, schizonts were treated with increasing concentra-
tions of MeSter and labeled with [
14C]-stearic acid. FAMEs were
then extracted and developed by silver-nitrate TLC. As expected,
IRBCs produced large amounts of radiolabeled oleic acid in the
absence of MeSter (Fig. 6A). This signal was strongly reduced
when schizonts were treated with 100 mM MeSter, and was
virtually abrogated in the presence of 1 mM MeSter. No oleic acid
production was observed in uninfected RBC. These results suggest
that MeSter inhibits oleic acid synthesis in vivo.
We subsequently employeda cell-freeassaytodeterminewhether
MeSter directly targets PfSCD. In this assay, schizont lysates were
incubated with [
14C]-stearoyl-CoA in the presence of increasing
concentrations of MeSter. FAMEs were then extracted and
developed by silver-nitrate TLC. Fig. 6B demonstrates that PfSCD
was inhibited by MeSter in a dose-dependent manner. Quantitative
analysis of the radiolabeled spots corresponding to oleic acid
enabled us to derive an IC50 value for MeSter of 105 mM (Fig. 6B).
Figure 4. Stearoyl-CoA desaturase activity in a P. falciparum cell-free assay. (A) In vitro conversion of stearoyl-CoA to oleoyl-CoA in P.
falciparum 3D7 schizont lysates, measured as a function of protein concentration. The reaction mix contained 0 to 2 mg of total lysate proteins, [
14C]-
stearoyl-CoA, and 2 mM NADPH, and was incubated for 30 min at 37uC. Following extraction of FAMEs, equal volumes of each sample (30%) were
loaded on TLC plates and resolved using petroleum ether/diethyl ether (17/3, v/v). Radiolabeled FAMEs were revealed after overnight exposure to a
Kodak Biomax MR film. Spots corresponding to oleic acid were scraped from the TLC plate and counted. Results are expressed as picomoles of oleic
acid produced. (B) In vitro conversion of stearoyl-CoA as a function of reaction time. The reaction mix containing 500 mg total proteins, [
14C]-stearoyl-
CoA, and 2 mM NADPH, and was incubated at 37uC for various durations. Following extraction of FAMEs, equal volumes of each sample (25%) were
loaded on TLC plates, resolved and revealed as described above. Results are expressed as picomoles of oleic acid produced. (C) In vitro conversion of
stearoyl-CoA as a function of the substrate concentration. Increasing concentrations of [
14C]-stearoyl-CoA, ranging from 2 to 200 mM, were mixed
together with 500 mg total protein and 2 mM NADPH, and the reactions incubated for 5 min at 37uC. Following extraction of FAMEs, equal volumes
of each sample (20%) were loaded on a TLC plate, resolved and revealed as described above. Oleic acid methyl esters were scraped from the TLC
plate and counted to allow direct quantification of the enzymatic reaction. The specific activity is expressed in picomoles of oleoyl-CoA formed/hr/mg
of input protein. The inset corresponds to the Lineweaver-Burke plot of the results. Results are expressed as a mean of 2 independent experiments.
(D) NADPH dependency of the Stearoyl-CoA desaturase activity. Schizont membranes were incubated with [
14C]-stearoyl-CoA either in the absence
(2) or presence of 2 mM NADH or NADPH. Samples were processed as described in (A) and FAMEs were analyzed by TLC/autroradiography. Each
condition was performed in duplicate.
doi:10.1371/journal.pone.0006889.g004
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oleic acid could be incorporated into more complex parasite lipids
such as neutral lipids or phospholipids. With MeSter specifically
inhibiting the conversion of stearic acid to oleic acid, we reasoned
that a comparative analysis of the total lipid profile of untreated and
MeSter-treated parasites would identify the lipids that contain
stearoyl-originating oleic acid. Schizonts were labeled with [
14C]-
stearic acid, treated or untreated with MeSter, and the total lipids
were extracted and resolved by TLC using heptane/diisopropyl
oxide/acetic acid. Fig. 6C indicates that high doses of MeSter
correlated to low signals corresponding to triacylglycerol (TAG),
1,2-diacylglycerol (DAG) and phospholipids (PL), when compared
to untreated control cells. Equal counts were loaded in each lane for
direct comparison of the lipid profiles, indicating that most of the
counts were recovered in the free FAs in parasites treated with high
concentrations of MeSter. Together, these results suggest that newly
synthesized oleic acid is incorporated into TAGs, 1,2-DAGs and
phospholipids. Additional experiments revealed that newly synthe-
sized oleic acid was present in phosphatidylcholine, phosphatidy-
lethanolamine, phosphatidylinositol and to a lesser extent phospha-
tidic acid (data not shown). These data provide evidence that oleate
represents a major FA in plasmodial phospholipids and is actively
incorporated into parasite lipids [50,51,52].
Antiplasmodial activity of methyl-sterculate
The mechanism of action of MeSter prompted us to investigate
whether this inhibitor was active against P. falciparum asexual blood
stage parasites. The structures of sterculic acid, the parental
natural compound and its methyl ester (MeSter) and related
analogues are depicted in Fig. 7. Our initial work using various
concentrations of human serum in the medium (ranging from 2%
to 20%) indicated that the maximal antiplasmodial activity of
MeSter was obtained in the presence of 4% serum (data not
shown), corresponding to approximately 0.3 mM oleic acid in the
culture medium. Therefore, the 4% serum concentration was used
in all subsequent experiments. Using a modified Desjardins test
[27], MeSter was found to exhibit significant antimalarial activity
against 3D7 parasites, with an IC50 value of 87 mM. The
antimalarial activity of MeSter analogs is presented in Fig. 7.
Among all the analogs, the methoxy-containing analogue EH87
was found to be the most active, with an IC50 value of 41 mM.
To link the antimalarial activity of MeSter to its capacity to
inhibit D9-desaturase-dependent oleic acid biosynthesis, we
generated an isobologram to test for interactions between the
inhibitor (MeSter) and the final reaction product (oleic acid) [53].
The graph presented in Figure S2 (left panel) is strongly suggestive
of antagonism between the two molecules [54]. This observation is
also supported by the fact that supplementation with exogenous
oleic acid (25 mM) partially reverses the antimalarial activity of
MeSter (Figure S2, right panel). The IC50 value of oleic acid
against P. falciparum was found to be around 150 mM (data not
shown), consistently with a previous report [55]. Because the fatty
acid composition is extremely important to provide the approp-
riate physical and biological membrane properties, high concen-
trations of oleic acid undoubtedly alter the fatty acid composition
equilibrium, ultimately leading to parasite death.
Figure 5. Localization of PfSCD-GFP in the parasite endoplasmic reticulum. (A) Direct fluorescence assays of PfSCD-GFP-expressing P.
falciparum parasites (strain Dd2
attB::Pfscd-gfp) with GFP (green), ER Tracker (red), and nuclear staining with Hoechst 33342 (blue). Images represent
various stages of the erythrocytic cycle, respectively from top to bottom: early trophozoite, late trophozoite and segmented schizont. (B)
Colocalization studies. PfSCD-GFP was colocalized with different compartment markers: ER (PfBip, PfDSI), cis-Golgi (PfERD2), mitochondria
(MitoTracker Red), and apicoplast (PfACP).
doi:10.1371/journal.pone.0006889.g005
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to MeSter, parasite cultures were synchronized and the effect of
the inhibitor was tested throughout the cycle. In this assay, various
concentrations of MeSter were delivered to parasites for a fixed
period of 6 hrs. Cells were then washed and resuspended in fresh
medium, and the viability determined at 52 hrs. The resulting
curves are depicted in Fig. 8A, and produced IC50 values of
310 mM, 162 mM and 99 mM for rings, trophozoites and
schizonts, respectively. These results indicated that all stages were
sensitive to killing by MeSter.
The potential of MeSter to inhibit intraerythrocytic growth of
the parasite was further evaluated in a time-course experiment.
This was achieved following a protocol illustrated in Fig. 8B (upper
panel). Briefly, we performed a time-course analysis of drug
contact on each parasite stage by delivering the drug to parasites at
10X IC50 for various times (ranging from 30 min to 9 hrs). After
this time of contact, the drug was washed out, parasites were
resuspended in fresh medium, and the parasite viability checked
after the end of the first complete cycle at time 52 hrs. The graph
in Fig. 8B shows the viability curves obtained for each stage. All
curves reached the X-axis of the graph or 0% control after 7 hrs of
contact, indicating that MeSter at 10X IC50 irreversibly affected
parasite viability, regardless of the stage. Thus, MeSter produced a
parasitocidal effect against cultured P. falciparum after 7 hrs. The
fastest cidal effect was observed with ring stage parasites (viability
was decreased by 80% after 30 min of contact with the drug),
indicating that the drug impacted these early stages more rapidly
than the mature stages.
Morphological evolution of MeSter-treated parasites
Morphological and kinetic changes induced by treatment of the
IRBCs with MeSter were monitored by Giemsa-staining of blood
Figure 6. Inhibition of oleic acid synthesis by methyl sterculate. (A) P. falciparum 3D7-infected RBC were either left untreated or were treated
for 1 hr with MeSter concentrations corresponding to 16or 106the IC50 value, and subsequently labeled with [
14C]-stearic acid for an additional
4 hrs. Non-infected red blood cells (RBC) were used as a negative control. Following extraction, FAs were methyl-esterified and equal volumes were
loaded on a TLC plate and resolved as described in the Experimental Procedures. (B) Inhibition of the stearoyl-CoA desaturase activity in parasite
lysates. Crude extracts (500 mg total protein) were preincubated for 10 min at 37uC with 2 mM NADPH, in the presence of increasing concentrations
of MeSter as indicated, prior to the addition of [
14C]-stearoyl-CoA. After an additional 5 min incubation at 37uC, FAMEs were extracted, methyl-
esterified and equal amounts of radioactivity counts were loaded on a TLC plate. The upper panel corresponds to the autoradiogram and the lower
panel represents the curve obtained after scrapping the OAME spots, illustrating the effect of MeSter on oleic acid production. (C) Effect of MeSter
treatment on parasite lipid composition. P. falciparum IRBCs were treated or untreated with MeSter, corresponding to 16or 106the IC50 value, for
1 hr. Parasites were subsequently labeled with [
14C]-stearic acid for an additional 4 hrs. Following extraction, the same amounts of radioactivity were
loaded and neutral lipids were resolved as described in the Experimental Procedures. DAGs, diacylglyerols; FFA, free fatty acids; PLs, phospholipids;
TAG, triacylglycerols.
doi:10.1371/journal.pone.0006889.g006
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and 10-fold the IC50 value. Representative images of the
morphological evolution are presented in Fig. 9. In control cells,
ring stage parasites (T0–18 hrs) show a large, hemoglobin-
containing vacuole with no pigment visible in light microscopy.
Between 18 and 24 hrs post-invasion, the pigment appears and the
size of the food vacuole is reduced. From 36 hrs post-invasion,
they undergo schizogonia, the nucleus starts to divide and the
pigment increases in size. No significant changes were observed in
treated parasites during the first 18 hrs, i.e. 12 hrs after drug
addition. However, important abnormalities began to appear after
24 hrs. At a low dose of MeSter (2X IC50), the appearance of the
pigment and the reduction of the hemoglobin-containing vacuole
are delayed, suggesting a slowdown of growth during the ring
stage. From 30 up to 52 hrs post-invasion, treated parasites remain
morphologically similar to untreated parasites at 30 hrs, suggesting
that the development is blocked in the mid-trophozoı ¨te stage. High
doses (10X IC50) of MeSter led to pycnotic parasites, suggesting
that they had already engaged a cell death process.
Discussion
Substantial evidence indicates that phospholipid and neutral
lipid biosynthesis in P. falciparum asexual blood stages relies
primarily on the uptake of FAs from host plasma [2,4,12,50].
Biochemical studies with Plasmodium-infected erythrocytes have
demonstrated that intracellular transacylation reactions or release
of FA moieties from intact phospholipid molecules do not occur to
a significant level [56]. Our study extends these observations by
finding that P. falciparum is able to unsaturate scavenged stearic
acid, producing oleic acid, and that the D9-desaturase activity
appears essential for parasite blood stage growth.
Here, we have reported and characterized the activity of P.
falciparum stearoyl-CoA D9-desaturase (PfSCD), which catalyzes
the conversion of stearoyl-CoA to oleoyl-CoA. Our genome
mining studies identified PFE0555w as a putative SCD. This
protein showed an unusually high number of predicted trans-
membrane domains when compared to most mammalian SCDs.
We posit that this was, at least in part, responsible for the failure to
express this protein in E. coli. Several lines of evidence nevertheless
indicate that this protein represents the appropriate candidate.
First, PFE0555w exhibits strong similarity with other mammalian
SCDs, although it possesses additional N-terminal and C-terminal
extensions. Examination of the primary sequence reveals the
presence of the three His boxes in regions Ia, Ib and II, a signature
feature of stearoyl-CoA desaturases [13]. Second, transgenic
parasites overexpressing a PFE0555w-GFP fusion localized this
protein to the ER, a feature also shared with mice, rat and yeast
SCDs [32,34]. It is noteworthy that PFE0555w was originally
predicted to be an apicoplast protein [57], however we find that
the sequence lacks the typical apicoplast targeting signals. Third,
we have cloned and overexpressed the central domain of
PFE0555w (residues 262 to 647, termed PFE0555w-C) in M. bovis
BCG, an organism whose stearoyl-CoA desaturase (DesA3) has
been reported to be a target of the antitubercular thiourea drug
isoxyl that inhibits oleic acid production [15]. We observed a two-
fold decrease in susceptibility to isoxyl in M. bovis BCG strains
overexpressing plasmodial PFE0555w-C, when compared to the
control strain (Figure S3). These results are similar to those
obtained by Phetsuksiri et al. [15], who reported that a M. bovis
BCG strain overexpressing DesA3 exhibited a two-fold increase in
resistance against isoxyl. This implies that the central domain of
PFE0555w, like DesA3, represents a functional target of isoxyl in
mycobacteria. These findings strongly suggest that PFE0555w
shares a similar activity with the mycobacterial stearoyl-CoA
desaturase DesA3 and lead us to posit that PFE0555w is PfSCD.
Finally, functional analysis of transgenic parasites overexpressing
PFE0555w clearly demonstrated a significant 2-fold increase in
stearic acid to oleic acid conversion at the late ring stage,
compared to the parental strain. It is noteworthy that SCDs are
usually part of a multiprotein complex, along with cytochrome b5
and NADPH-cytochrome b5 reductase. Therefore, overexpression
of only one partner of this complex, such as PFE0555w, may limit
an important increase in SCD activity.
Previous reports have failed to find evidence that intraerythro-
cytic P. falciparum parasites can elongate or desaturate fatty acids
[5,12]. In this study, we have developed a sensitive in vitro assay
that enabled us to observe the conversion of stearic acid to oleic
acid in both P. falciparum crude extracts and membranes. Although
mammalian SCDs desaturate several substrates such as palmitoyl-
CoA and stearoyl-CoA [40], PfSCD appears to be highly specific
to stearoyl-CoA, as no palmitoleoyl was formed using palmitate as
a primer. Moreover, our study revealed that stearoyl-CoA
desaturase activity was predominant at the later stages of the
Figure 7. Structure and antimalarial activity of methyl sterculate and its analogs. Chemical structure of sterculic acid, as well as methyl
sterculate (MeSter) and some derivatives. Inhibition of the intraerythrocytic growth of P. falciparum 3D7 by each compound is expressed as the
mean6SEM IC50 value (in mM). Each compound was tested in duplicate on three separate occasions. NE, no effect on parasite viability was observed
at the highest concentration tested (1 mM).
doi:10.1371/journal.pone.0006889.g007
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an extensive build-up of membranes required for the formation of
merozoites. This is in agreement with earlier work showing that
parasite lipid biosynthetic activities are maximal at the schizont
stage [50]. The increased SCD activity is also evidenced by the
high induction of specific Pfscd transcripts in late trophozoites
(harvested 36 hrs post-invasion), producing a 50-fold increase
compared to the ring stage.
We provide here clear evidence that PfSCD is associated with
the P. falciparum ER. This indicates that desaturation of stearoyl-
CoA does not occur in the apicoplast, the site of FA elongation by
the functional FAS-II system [8,9]. However, it remains possible
that FAs, such as oleic acid, may be produced using a system that
is different from the conventional type I or type II fatty acid
synthases, at least during the asexual erythrocytic cell cycle.
Indeed, recent work indicates that although the FAS-II system is
dispensable during the asexual blood stages, it is required for FA
synthesis during the infectious liver stage [10]. This was
demonstrated in both P. falciparum and P. berghei using disruption
mutants of the fabI gene encoding the FAS-II enzyme enoyl ACP
reductase. Evidence that the FAS-II pathway is not active in
asexual blood stages, but is required for the maturation of liver
stages, was also provided by studies of P. yoelii knockout parasites
lacking the fabB/F or fabZ genes [11]. These results imply the
existence of a separate mechanism of FA synthesis during asexual
blood stage development. Interestingly, an elegant study recently
Figure 8. Life cycle-dependent sensitivities of P. falciparum to methyl sterculate throughout asexual blood stage growth. (A) Stage-
specific MeSter IC50 value. This value was determined using a range of MeSter concentrations at each stage, following 6 hrs of parasite exposure to
the drug. The medium was then removed, cells were washed twice, and fresh medium was added. Viability was determined after 52 hrs by measuring
the parasite ability to incorporate [
3H]-hypoxanthine for a further 18 hrs. Results are expressed as the mean of 2 independent experiments. (B) Time-
course of parasite growth inhibition by MeSter. The upper panel is a schematic representation of the experimental protocol. Drug was added at each
developmental stage for the indicated times. The medium was then removed, cells were washed twice, and fresh medium was added. Viability was
determined after 52 hrs by measuring the ability of the parasites to incorporate [
3H]-hypoxanthine for a further 18 hrs. The graph in the lower panel
illustrates the sensitivity of each parasite stage to MeSter as a function of the duration of exposure to compound. Results are expressed as the percent
[
3H]-hypoxanthine incorporation compared to non-treated parasites, and reflect the mean of 2 independent experiments.
doi:10.1371/journal.pone.0006889.g008
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somal elongase pathway that differs from FAS-I or FAS-II [58].
Similar elongases are encoded by the P. falciparum genome [(PfD1
(NP_703294), PfD2 (NP_704739), and PfE (XP_966049)] [59],
and their role in FA biogenesis remains to be investigated. It is
tempting to speculate that the ER, rather than the apicoplast,
represents the site of FA elongation and desaturation in Plasmodium
parasites during intraerythrocytic growth. These FAs could then
directly be utilized for the synthesis of phospholipids and
membrane biogenesis. Interestingly, the P. falciparum PfGatp
protein, which catalyzes the first step of phospholipid biosynthesis
by controlling the acylation of glycerol 3-phosphate at the sn-1
position, is also an integral membrane protein resident in the ER
[60].
Cyclopropene FAs, such as sterculic acid, are known to be
specific inhibitors of D9-desaturases [48,49]. Our experiments with
methyl sterculate demonstrated a pronounced inhibition of D9-
stearoyl-CoA desaturase activity in P. falciparum. These data
indicate that MeSter not only inhibited the production of oleic
acid in living parasites in a dose-dependent manner, but also
inhibited D9-stearoyl-CoA desaturase activity in lysates with an
IC50 value similar to that required for 50% inhibition of parasite
growth. This prompted us to analyze the fate of newly formed
oleic acid in parasite lipids. Results showed that oleic acid was
incorporated into essentially all lipids, including neutral lipids and
phospholipids.
Although the molecular mechanisms by which MeSter leads to
parasite cell death remains obscure, we propose several hypotheses
to explain the effect of oleic acid synthesis inhibition. The first is
that MeSter considerably depletes parasites of newly synthesized
oleic acid, thus changing the stearic/oleic acid ratio. This
imbalance in the saturated/unsaturated lipid ratio could have
important consequences regarding membrane fluidity and cellular
trafficking within the parasite. Therefore, the antimalarial activity
of MeSter would directly depend on a profound alteration of
membrane fluidity. An alternative hypothesis is that while newly
synthesized oleic acid is incorporated in neutral lipids and
phospholipids, it is also required for another important lipid that
is involved in a specific metabolic process or signal transduction
event. Interestingly elucidation of the P. falciparum glycosylpho-
sphatidylinositol (GPI) moieties that anchor parasite proteins to the
surface of the asexual blood stage merozoite reveal these to be
enriched in C16:0 (palmitic acid), C18:0 (stearic acid) and C18:1
(oleic acid), with each GPI moiety typically containing two
saturated and one monounsaturated FA [61]. A change in the
stoichiometry of these unsaturated and saturated FA through
inhibition of PfSCD could therefore be rapidly detrimental to
parasite growth.
At low concentration, MeSter induces a delay in the evolution
of the ring form followed by an arrest of the parasite development
around the mid-trophozoı ¨te stage. This growth defect may be due
to an alteration of hemoglobin digestion. The association of lipid
bodies and substantial amounts of DAG and TAG with the food
vacuole suggests that neutral lipids and their precursors may also
assist in the crystallization of haematin, and play a role in heme
detoxification during the early trophozoite stage [62]. Since newly
synthesized oleic acid is incorporated into most lipids, including
DAG and TAG (Fig. 6C), it can then be speculated that
impairment of oleic acid synthesis may have consequences on
the content or composition of the food vacuole lipids, thus
affecting hemozoin formation. However, this requires to be further
investigated.
Assays to monitor the antimalarial activity of MeSter indicated
that all erythrocytic stages were sensitive to inhibition by this
compound. Time-course experiments indicated that the ring stage
is more rapidly inhibited, compared to the other stages. This is a
particularly unexpected observation as relatively few antimalarial
agents, notably artemisinin [63], triclosan [64], and the choline
analog T3 [65], show rapid onset of inhibition of ring stage
parasites. Most antimalarials, including chloroquine and the
antifolates, are usually more effective during late erythrocytic
stages [63,66,67]. However, the reason why rings are more rapidly
inhibited than the other stages is presently not known.
We also designed and synthesized several MeSter analogues for
structure-function studies. Methyl malvalate, which has cyclopro-
pene at the 8,9- position in the chain relative to the ester, showed an
IC50 value twice that of MeSter. In contrast EH57, which has the
cyclopropene at the 10,11 position, had an IC50 value similar to
MeSter. An earlier study of related compounds showed that
desaturase activity required at least one of the carbons of the
cyclopropene to be in the 9 or 10-position [68]. Among the
analogues tested here, only EH87 (with a methoxy group in position
Figure 9. Effect of MeSter on parasite morphology. MeSter at 2-fold and 10-fold the IC50 was added to P. falciparum 6 hrs after synchronization
(T0). Giemsa-stained blood smears were performed every 6 hrs until reinvasion of the control dish 52 hrs later. Representative images are shown.
doi:10.1371/journal.pone.0006889.g009
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improved IC50 value over MeSter. Yet the closely related alcohol
EH164, acetate EH172 and silyl ether EH171 showed no activity in
our assay. With the latter compounds, this could reflect a steric
effect, although the inactivity of EH164 remains to be accounted.
These results raise the possibility of designing more potent sterculic
acid mimics and in particular, studying the effect of the
stereochemistry of substituents adjacent to the cyclopropene ring.
In conclusion, oleic acid synthesis in P. falciparum is strongly
supported by our molecular and biochemical data. The inhibition
data highlight the essential nature of this desaturation product and
the potential of generating sterculic acid analogs with increased
antimalarial activities. Given the requirements for new antimala-
rials with novel modes of action, we propose that fatty acid
metabolism, which appears to achieve a stage-specific balance
between salvage from the host and modification by the parasite,
represents an attractive process with significant therapeutic value.
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